This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vital Signs Weakens After Ex-CFO Questions Accounting

Shares of Vital Signs (VITL) were dropping a day after the company posted a loss for the latest quarter and found itself fending off allegations of accounting improprieties from its former chief financial officer.

The former CFO, Joseph Bourgart, filed a lawsuit against the company, saying that he had warned other Vital Signs executives about accounting rules violations. Bourgart resigned in January, the company said, after being told he would be fired. Vital Signs denied the allegations and said the lawsuit was "asserting baseless claims."

The stock was lately down $4.10, or 14%, to $25.25.

Vital Signs, in a press release, said that Bourgart was told he would be fired because of evidence that he had anonymously forwarded confidential corporate information to an investor. At least some of the allegations regarding accounting rules violations would have occured while Bourgart was CFO. During that time, the company said, he certified the accounting results in filings made with the Securities and Exchange Commission.

The company, which makes products for use in, among other things, anesthesia and respiratory procedures, also said Bourgart had no objections to the presentation of the company's 10-K annual report after being asked to review it last year.

Bourgart told Reuters he initially had doubts that the company's inventory was accurately reported in August and suggested a writedown might be needed. Because his doubts couldn't be fully proven, Bourgart said he certified the company's financial results, according to the report. When evidence did appear in September, he brought it to the attention of other executives, but his allegations were ignored, Bourgart told Reuters.

Vital Signs replaced Bourgart with Frederick Schiff, the former financial chief at Bristol-Myers Squibb (BMY). Schiff left his previous employer in April 2002. The SEC last year investigated Bristol's accounting methods. Bourgart also named Schiff and Vital Signs President and CEO Terry Wall in his lawsuit.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs